FDA Recall Announcement MedShadow Foundation: More about Compounded GLP-1 Recalls and Compounding Pharmacies Safety and Misleading Marketing of Compounded GLP-1s Levothyroxine Sodium Tablets (Synthroid generic) Recall by Accord Healthcare Accord Healthcare is recalling 54,432 bottles of Levothyroxine Sodium Tablets, 88 mcg (90-count bottles), due to subpotency (less than the required amount of active ingredient) discovered during long-term stability testing
**Serious Side Effects and Risks:** While less common, Tirzepatide (Zepbound) has potential serious risks that require immediate attention: **BOXED WARNING (FDAs Most Serious Warning): Risk of Thyroid C-cell Tumors** * **What it means:** In studies with rats, Tirzepatide caused thyroid C-cell tumors, including a type of thyroid cancer called Medullary Thyroid Carcinoma (MTC)
At Desert Sands, every medical weight loss program includes InBody body composition scanning a clinical-grade analysis that measures exactly what your body is made of, not just how much it weighs
*Correspondence: Linda de Bont, [email protected] Rouhier, [email protected] This article was submitted to Plant Abiotic Stress, a section of the journal Frontiers in Plant Science Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Nausea is not always a reason to stop treatment